Analyst consensus rating
BioVie Analyst Rating: none
Direct answer
BioVie's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.26.
Forecast evidence checked September 6, 2026.
Get free BioVie email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.00
- Average price target
- $5.26
- High price target
- $5.51
- Low price target
- $5.00
- Low target gap
- +150%
- Target upside
- +162.8%
- High target gap
- +175.5%
- Target range width
- 25.5%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- September 6, 2026
- Valid through
- September 13, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioVie?
BioVie has a verified none consensus. The same dataset has an average price target of $5.26.
How far are BioVie's low and high targets from the recorded price?
The low target implies +150%, while the high target implies +175.5%.
How many analysts are included in BioVie's consensus?
The verified consensus includes 2 analysts.
How is BioVie's target upside or downside calculated?
The average target of $5.26 is divided by the recorded price of $2.00, then one is subtracted to produce +162.8%. This does not guarantee a future return.
When was BioVie's analyst forecast verified?
The data was verified on 2026-09-06. The dataset is valid through 2026-09-13.